Lipids

Citations 1-2 of 2 total displayed.

Most recent content (1 Nov 2009):

Original Articles
Number Needed to Treat With Rosuvastatin to Prevent First Cardiovascular Events and Death Among Men and Women With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein: Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)

Paul M Ridker, Jean G. MacFadyen, Francisco A.H. Fonseca, Jacques Genest, Antonio M. Gotto, John J.P. Kastelein, Wolfgang Koenig, Peter Libby, Alberto J. Lorenzatti, Børge G. Nordestgaard, James Shepherd, James T. Willerson, Robert J. Glynn for the JUPITER Study Group
Circ Cardiovasc Qual Outcomes 2009;2:616-623; published online before print as doi:10.1161/CIRCOUTCOMES.109.848473 [Abstract] [Full text]  

Past content (since Nov 2008):

Cardiovascular Perspectives
Prevention of Future Cardiovascular Disease in High-Risk Pediatric Patients: A Role for Lipid Lowering Therapy?

Sara K. Pasquali and Jennifer S. Li
Circ Cardiovasc Qual Outcomes 2008;1:131-133, doi:10.1161/CIRCOUTCOMES.108.819235 [Full text]